POLE and non-small cell lung carcinoma: The top gene alterations in HER2‐mutant NSCLC including TP53, SETD2, PTPRT, PBRM1, KMT2C, GRIN2A, DNMT3B, ZFHX3, TET2, TERT, RBM10, RB1, PTPRD, PPP2R1A, POLE, PIK3R2, PIK3CA, PDGFRB (Figure 4C).